Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc sell Snowman

Start price
€48.17
18.12.20 / 50%
Target price
€27.00
18.06.21
Performance (%)
14.83%
End price
€55.31
19.01.21
Summary
This prediction ended on 19.01.21 with a price of €55.31. The prediction closed with a disappointing performance of 14.83%. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Gilead Sciences Inc -2.860% -2.860% -18.596% 11.378%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to Snowman what are the pros and cons of Gilead Sciences Inc for the foreseeable future?

Pros
Top 10 in its market
Good rating
Medium risks for its business
Future proof or reliable business model
Cons
Bad culture

Comments by Snowman for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Sell
Perf. (%) 14.83%
Target price 27.000
Change
Ends at 18.06.21

Gilead Sciences hatte in diesem Corona Jahr wegen Remdesivir ein sehr lokales, isoliertes Hoch. Hier war viel Hoffnung auf eine Erlösung von Corona dabei, die sich, wie man schnell absehen konnte, als Illusion erwies. Der vor allem in Amerika aufgrund von extremer Profitgier ruinierte Ruf wird der Aktie weiterhin zu schaffen machen. Da es viele Alternativen für Anleger gibt, werden wir Gilead wahrscheinlich bald als sogar deutlich unterbewerteten Wert sehen, bevor es dann irgendwann wieder aufwärts geht.

In the thread Trading Gilead Sciences Inc
Prediction Sell
Perf. (%) 14.83%
Target price 27.000
Change
Ends at 18.06.21

Sell beendet

Stopped prediction by Snowman for Gilead Sciences Inc

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€62.75
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture